Trump has been pushing for higher interest rates to combat inflation, and that could keep mortgage rates elevated, Cox said.
“The Fed is in a really tough spot,” she said.
Still, any potential infrastructure spending could benefit building materials and construction companies, experts said.
Trump has said he wants to invest in infrastructure, and that could stoke demand for materials such as steel, copper and lumber, experts said.
“Infrastructure spending is something that could be a boon for that sector,” said Rea, of Salem Investment Counselors.
However, the effects of such spending could take time to materialize, experts said.
— Lorie Konish
Cryptocurrency
Bitcoin tokens sit in a wallet created in 2023.
Yuriko Nakao | Bloomberg | Getty Images
Trump didn’t take significant action on cryptocurrency during his first term, but that could change in his second term, experts said.
Trump’s administration has been skeptical of cryptocurrency, and that could lead to crackdowns on digital assets, experts said.
“There have been some rumblings about additional regulation,” said Spinelli, of Halbert Hargrove.
However, the impact of such regulation on the sector remains to be seen, experts said.
Bitcoin and other cryptocurrencies have been volatile in recent years, so any regulatory changes could have significant effects on their prices, experts said.
“It’s been a wild ride,” Spinelli said.
— Lorie Konish
to lead the Food and Drug Administration (FDA) in his new administration, sparking concerns among health care experts about the future of drug regulation and public health. Kennedy, a prominent anti-vaccine advocate, has been vocal about his skepticism of vaccine safety and efficacy, raising fears that the FDA under his leadership may loosen regulations on vaccines and other pharmaceuticals.
This uncertainty in drug regulation could have far-reaching implications for the health care industry, with pharmaceutical companies potentially facing increased scrutiny and backlash from consumers. The possibility of deregulation in the health care sector under Trump could also impact the affordability and accessibility of medications for patients, as well as the overall quality of health care services.
Additionally, Trump’s stance on health care policy, including his plans to repeal and replace the Affordable Care Act (ACA), could further disrupt the industry and create instability for insurers, providers, and patients. The potential for changes in health care legislation and regulations could lead to uncertainty in the market, affecting the financial performance of health care companies and the overall delivery of care to patients.
Despite these challenges, there may also be opportunities for innovation and growth in the health care sector under Trump’s administration. His focus on deregulation and market-based solutions could spur competition and drive efficiency in the industry, leading to improved access to care and lower costs for patients. Trump’s emphasis on innovation and technology in health care could also pave the way for advancements in medical research, treatment options, and patient care.
Overall, the health care industry faces a period of uncertainty and change under Trump’s administration, with potential risks and rewards for stakeholders across the sector. As policies and regulations evolve, health care companies, providers, and consumers will need to adapt to a shifting landscape and navigate the challenges and opportunities that lie ahead. As the head of the Department of Health and Human Services, I am closely monitoring the potential confirmation of Robert F. Kennedy Jr. to the U.S. Senate. RFK’s stance as a prominent vaccine skeptic could have significant implications for the health-care sector, particularly for big vaccine makers such as Merck, Pfizer, and Moderna. This uncertainty poses a “huge wild card” for the industry, according to experts.
In addition to concerns about vaccine skepticism, cuts to Medicaid and the Affordable Care Act (Obamacare) are also on the table. These cuts are seen as a way to reduce government spending and raise funds for a tax-cut package. Companies like Centene, HCA Healthcare, and UnitedHealth may be affected by lower volumes of Medicaid patients or consumers facing higher health-care premiums post-ACA subsidy loss.
Moreover, medical tech providers reliant on electronics with semiconductors from China could face burdensome tariffs. On the flip side, deregulation could benefit pharmaceutical companies like Thermo Fisher Scientific and Charles River Laboratories, as faster FDA approvals may be on the horizon.
Vivek Ramaswamy, co-head of the new advisory panel “Department of Government Efficiency,” has advocated for streamlined drug approvals, while Kennedy has pushed for more oversight. This dichotomy creates uncertainty in the industry, leaving experts questioning the ultimate outcome.
Moving on to the retail sector, potential tax cuts could boost consumers’ disposable income, benefiting companies selling consumer electronics, clothing, luxury goods, and more. However, the likelihood of tariffs poses a significant risk. Retailers may pass on these additional costs to consumers, impacting a wide range of goods, from apparel to appliances.
Companies like Home Depot, Lowe’s, and Walmart, which import a significant portion of their goods, could be particularly affected by tariffs. Investors are advised to consider owning retailers with diversified inventory sources and minimal debt, such as TJX Companies.
In the technology sector, the Magnificent Seven companies, including Amazon, Apple, Alphabet, Meta, Microsoft, Nvidia, and Tesla, have been driving strong performance. Antitrust issues loom large, especially regarding Google’s online search dominance. Tariffs could impact sales and raw material costs, but firms like Salem Investment Counselors remain bullish on tech, particularly in generative artificial intelligence.
However, high valuations in the technology sector may signal declining future returns, prompting caution among investors. Prospective investors should consider the historical trends and potential risks associated with buying into the sector at current valuations.
Overall, the health-care, retail, and technology sectors face uncertainty and potential challenges ahead. As the head of the Department of Health and Human Services, it is crucial to closely monitor these developments and adapt strategies to navigate the evolving landscape. The world of technology is constantly evolving, and one area that has seen significant advancements in recent years is artificial intelligence (AI). AI refers to the development of computer systems that can perform tasks that typically require human intelligence, such as visual perception, speech recognition, decision-making, and language translation.
One of the most exciting developments in AI is the emergence of deep learning, a subset of machine learning that uses artificial neural networks to mimic the way the human brain processes information. Deep learning has led to breakthroughs in areas such as image and speech recognition, natural language processing, and autonomous driving.
Another major advancement in AI is the use of reinforcement learning, a type of machine learning where an algorithm learns to perform a task through trial and error. This approach has been particularly successful in training AI agents to play complex games like chess, Go, and video games.
AI has also made significant strides in the field of healthcare. Researchers are using AI to analyze medical images, identify patterns in patient data, and develop personalized treatment plans. AI-powered diagnostic tools are helping doctors detect diseases earlier and more accurately, leading to better patient outcomes.
In the business world, AI is being used to automate repetitive tasks, improve customer service, and optimize operations. Chatbots powered by AI are becoming increasingly common in customer service, providing instant responses to customer inquiries and resolving issues efficiently.
Despite the many benefits of AI, there are also concerns about its potential impact on society. Some worry that AI could lead to job loss as automation replaces human workers in various industries. There are also ethical concerns surrounding the use of AI in areas like facial recognition, surveillance, and autonomous weapons.
As AI continues to advance, it is crucial for policymakers, researchers, and industry leaders to work together to ensure that AI technologies are developed and deployed responsibly. This includes addressing issues related to bias, privacy, accountability, and transparency.
Overall, the future of AI is bright, with the potential to revolutionize industries, improve healthcare outcomes, and enhance our daily lives. By harnessing the power of AI in a responsible manner, we can unlock its full potential and create a more innovative and inclusive society.
